ペンダントポリマー:amino-β-cyclodextrin:siRNA ゲスト:ホスト ナノ粒子は,遺伝子サイレンシングのための効率的なベクターとして使用されます
Aditya Kulkarni1, Kyle DeFrees, Seok-Hee Hyun
1Department of Chemistry, Purdue University, 560 Oval Drive, West Lafayette, Indiana 47907, USA.
Journal of the American Chemical Society
|May 2, 2012
まとめ
新しい自己組み立てナノ粒子のシステムは,siRNA.を効果的に提供します. この新しいベクトルは,カチオン性β-サイクロデクストリンと分解性ポリマーから作られており,低毒性であり,既存の方法と比較して比較可能な遺伝子サイレンシングを示しています.
科学分野:
- バイオマテリアル科学 バイオマテリアル科学
- ナノテクノロジー ナノテクノロジー
- 遺伝子配送 遺伝子配送
背景:
- 安全で効果的なsiRNA配送ベクトルの開発は,遺伝子治療において極めて重要です.
- 既存の非ウイルスベクトルは,毒性と効率性に関する課題に直面することが多い.
- セルフアセンブリナノマテリアルは,標的型薬物および核酸の投与のための有望なプラットフォームを提供します.
研究 の 目的:
- siRNA配送のための新しい自己組み立てナノ粒子システムを開発し,特徴づけること.
- 開発されたベクトルの効率と細胞毒性を評価する.
- 新型のベクトルの性能を,ベンチマークトランスフェクション反応剤と比較する.
主な方法:
- 単位置換されたカチオンのβ-サイクロデクストリン誘導体の合成.
- ポリエチレングリコール (PEG) とコレステロール (Chol) グラフトによるポリウニルアルコール (PVA) の製剤は,酸性無活性結合による.
- siRNA.と2つの自己組み立てスキームを使用してナノ粒子形成の調査.
- ナノ粒子のサイズとゼータポテンシャルの特徴化.
- CHO-GFP細胞における細胞活性の評価と遺伝子サイレンシングの効率.
主要な成果:
- カチオンのβ-CD誘導体とChol-PVA-PEGポリマーがsiRNAで形成されたナノ粒子 (120-170 nm) の自己組み立て.
- ナノ粒子はわずかに負のゼータポテンシャルを示した.
- 新型ベクトルは,25 kDa bPEIと比較して1000倍低い細胞毒性を示した.
- 遺伝子サイレンシングの効率は,bPEIやLipofectamine 2000のようなベンチマーク反応剤に匹敵していた.
結論:
- 開発された自己組み立てシステムは,siRNA配送のためのナノ粒子を効果的に形成します.
- この新しいベクトルは,遺伝子サイレンスアプリケーションの低毒性の代替案を提供します.
- このアプローチは,非ウイルス性siRNAの治療法を進歩させる可能性を秘めています.
関連する概念動画
siRNA - Small Interfering RNAs
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
Experimental RNAi
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
RNA Interference
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Small interfering RNAs (siRNA)
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...


